These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21544271)

  • 21. Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis.
    Frazzoni M; Conigliaro R; Melotti G
    Aliment Pharmacol Ther; 2011 Mar; 33(5):601-6. PubMed ID: 21198705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects.
    Pasternak B; Hviid A
    N Engl J Med; 2010 Nov; 363(22):2114-23. PubMed ID: 21105793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton pump inhibitors: a better prescription is needed.
    Khara HS; Pitchumoni CS
    J Clin Gastroenterol; 2009 Jul; 43(6):597-8. PubMed ID: 19384247
    [No Abstract]   [Full Text] [Related]  

  • 24. Omeprazole-induced cough in a patient with gastroesophageal reflux disease.
    Reiche I; Tröger U; Martens-Lobenhoffer J; Kandulski A; Neumann H; Malfertheiner P; Bode-Böger SM
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):880-2. PubMed ID: 19801940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a dark side to long-term proton pump inhibitor therapy?
    Nealis TB; Howden CW
    Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prescription of PPI in Germany: too often, too long, too much?].
    Gross M; Labenz J
    MMW Fortschr Med; 2018 Feb; 160(2):37-40. PubMed ID: 29417513
    [No Abstract]   [Full Text] [Related]  

  • 27. On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor.
    Juul-Hansen P; Rydning A
    Aliment Pharmacol Ther; 2009 Jan; 29(2):207-12. PubMed ID: 19006541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton pump inhibitor use and enteric infections.
    Dial MS
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S10-6. PubMed ID: 19262540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gastroesophageal reflux and proton pump inhibitors: panacea or prescription abuse?].
    Mouterde O; Bellaïche M; Dumant C; Mallet E
    Arch Pediatr; 2010 Jun; 17(6):739-40. PubMed ID: 20654868
    [No Abstract]   [Full Text] [Related]  

  • 30. Proton pump inhibitor use and fracture risk - effect modification by histamine H1 receptor blockade. Observational case-control study using National Prescription Data.
    Abrahamsen B; Vestergaard P
    Bone; 2013 Nov; 57(1):269-71. PubMed ID: 23973557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW
    Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weakly acidic reflux.
    Tack J; Blondeau K
    Dig Dis; 2009; 27(1):58-61. PubMed ID: 19439962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease.
    Friedlander EA; Pallentino J; Miller SK; VanBeuge SS
    J Am Acad Nurse Pract; 2010 Dec; 22(12):674-83. PubMed ID: 21129076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gastroesophageal reflux disease--diagnosis and management].
    Wojtuń S; Gil J; Jałocha Ł; Błaszak A; Wojtkowiak M
    Pol Merkur Lekarski; 2009 May; 26(155):512-6. PubMed ID: 19606713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintenance treatment with proton pump inhibitors for reflux esophagitis in pediatric patients: a systematic literature analysis.
    Illueca M; Wernersson B; Henderson C; Lundborg P
    J Pediatr Gastroenterol Nutr; 2010 Dec; 51(6):733-40. PubMed ID: 20808247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Indications, Applications, and Risks of Proton Pump Inhibitors.
    Mössner J
    Dtsch Arztebl Int; 2016 Jul; 113(27-28):477-83. PubMed ID: 27476707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unexpected consequences of proton pump inhibitor use.
    Altman KW; Radosevich JA
    Otolaryngol Head Neck Surg; 2009 Nov; 141(5):564-6. PubMed ID: 19861191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton pump inhibitor failure--what are the therapeutic options?
    Fass R
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S33-8. PubMed ID: 19262545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Balancing the risks and benefits of proton pump inhibitors.
    Gill JM; Player MS; Metz DC
    Ann Fam Med; 2011; 9(3):200-2. PubMed ID: 21555747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.